NO941080D0 - Fluorinerte 17 ater - Google Patents

Fluorinerte 17 ater

Info

Publication number
NO941080D0
NO941080D0 NO941080A NO941080A NO941080D0 NO 941080 D0 NO941080 D0 NO 941080D0 NO 941080 A NO941080 A NO 941080A NO 941080 A NO941080 A NO 941080A NO 941080 D0 NO941080 D0 NO 941080D0
Authority
NO
Norway
Prior art keywords
hydrogen
fluorine
alkyl
image
double bond
Prior art date
Application number
NO941080A
Other languages
English (en)
Other versions
NO305401B1 (no
NO941080L (no
Inventor
Achille Panzeri
Marcella Nesi
Enrico Di Salle
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of NO941080D0 publication Critical patent/NO941080D0/no
Publication of NO941080L publication Critical patent/NO941080L/no
Publication of NO305401B1 publication Critical patent/NO305401B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Lubricants (AREA)
  • Glass Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO941080A 1992-07-31 1994-03-24 Fluorinerte 17<beta>-substituerte 4-aza-5<alfa>-androstan-3-on-derivater NO305401B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929216284A GB9216284D0 (en) 1992-07-31 1992-07-31 Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives
PCT/EP1993/002037 WO1994003475A1 (en) 1992-07-31 1993-07-29 FLUORINATED 17β-SUBSTITUTED 4-AZA-5α-ANDROSTAN-3-ONE DERIVATIVES

Publications (3)

Publication Number Publication Date
NO941080D0 true NO941080D0 (no) 1994-03-24
NO941080L NO941080L (no) 1994-05-18
NO305401B1 NO305401B1 (no) 1999-05-25

Family

ID=10719598

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941080A NO305401B1 (no) 1992-07-31 1994-03-24 Fluorinerte 17<beta>-substituerte 4-aza-5<alfa>-androstan-3-on-derivater

Country Status (29)

Country Link
US (1) US5407939A (no)
EP (1) EP0607400B1 (no)
JP (1) JP3325025B2 (no)
KR (1) KR100311547B1 (no)
CN (1) CN1041096C (no)
AT (1) ATE159951T1 (no)
AU (1) AU660562B2 (no)
CA (1) CA2120343A1 (no)
CZ (1) CZ286240B6 (no)
DE (1) DE69315050T2 (no)
DK (1) DK0607400T3 (no)
ES (1) ES2110620T3 (no)
FI (1) FI113778B (no)
GB (1) GB9216284D0 (no)
GR (1) GR3025546T3 (no)
HK (1) HK1011693A1 (no)
HU (2) HUT67043A (no)
IL (1) IL106520A (no)
MX (1) MX9304579A (no)
MY (1) MY109633A (no)
NO (1) NO305401B1 (no)
NZ (1) NZ254787A (no)
PH (1) PH29938A (no)
PL (1) PL178591B1 (no)
RU (1) RU2125061C1 (no)
TW (1) TW286319B (no)
UA (1) UA41291C2 (no)
WO (1) WO1994003475A1 (no)
ZA (1) ZA935481B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ258435A (en) * 1992-12-18 1997-05-26 Merck & Co Inc Prostatitis treatment; method using 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-l-en-3-ones
WO1995000531A1 (en) * 1993-06-24 1995-01-05 Richter Gedeon Vegyészeti Gyár Rt. NOVEL PROCESS FOR PREPARING 17β-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
RU2142956C1 (ru) * 1993-10-21 1999-12-20 Мерк Энд Ко., Инк. 16-замещенные 4-аза-андростаны, соединения, способы ингибирования, фармацевтическая композиция
GB9415178D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 4-azasteroids with side-chain fluoroketones
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US5595996A (en) * 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use
IT1275594B1 (it) * 1995-07-21 1997-08-06 Pharmacia S P A Ora Pharmacia Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5alfa-androst-1-ene-17beta-carbossammide
GB9518858D0 (en) * 1995-09-14 1995-11-15 Pharmacia Spa Phenylsubstituted 4-azasteroid fluoroderivatives
GB9727522D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Process for preparing carboxamido-4-azasteroids
US6645974B2 (en) * 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
AU2003218235B2 (en) * 2002-03-13 2008-05-15 Merck Sharp & Dohme Corp. Fluorinated 4-azasteroid derivatives as androgen receptor modulators
EP1641761A4 (en) * 2003-06-30 2008-05-14 Merck & Co Inc 17-ACETAMIDO-4-AZASTEROID DERIVATIVES AS MODULATORS OF THE ANDROGEN RECEPTOR
WO2005009949A2 (en) * 2003-06-30 2005-02-03 Merck & Co., Inc. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
CA2530182A1 (en) 2003-06-30 2005-01-20 Merck & Co., Inc. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
CN1816370A (zh) * 2003-06-30 2006-08-09 麦克公司 用作雄激素受体调节剂的17－乙酰氨基－4－氮杂甾族化合物衍生物
CA2537663A1 (en) 2003-09-10 2005-03-24 Merck & Co., Inc. 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
EP1663228A4 (en) * 2003-09-10 2010-10-06 Merck Sharp & Dohme USE OF 17-HETEROCYCLIC-4-AZASTEROIDIAN DERIVATIVES AS MODULATORS OF THE ANDROGEN RECEPTOR
US20080125399A1 (en) * 2004-04-08 2008-05-29 Jiabing Wang 17 Beta-Acetamide-4-Azasteroids As Androgen Receptor Modulators
JP2012506906A (ja) * 2008-10-28 2012-03-22 バイオマリン ファーマシューティカル インコーポレイテッド デカヒドロ−１ｈ−インデノキノリンおよびデカヒドロ−３ｈ−シクロペンタフェナントリジノンｃｙｐ１７インヒビター
KR102541494B1 (ko) 2019-09-11 2023-06-08 주식회사 엘지화학 고흡수성 수지의 제조 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
GB9002922D0 (en) * 1990-02-09 1990-04-04 Erba Carlo Spa 17 beta-substituted-4-aza-5 alpha-androstan-3-one derivatives and process for their preparation
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives
AUPP930799A0 (en) * 1999-03-18 1999-04-15 University Of Sydney, The Optical planar waveguide device and method of its fabrication

Also Published As

Publication number Publication date
GR3025546T3 (en) 1998-03-31
MX9304579A (es) 1994-02-28
RU2125061C1 (ru) 1999-01-20
US5407939A (en) 1995-04-18
CZ153893A3 (en) 1994-02-16
HK1011693A1 (en) 1999-07-16
WO1994003475A1 (en) 1994-02-17
GB9216284D0 (en) 1992-09-16
CZ286240B6 (cs) 2000-02-16
NO305401B1 (no) 1999-05-25
DE69315050D1 (de) 1997-12-11
ES2110620T3 (es) 1998-02-16
EP0607400B1 (en) 1997-11-05
EP0607400A1 (en) 1994-07-27
CA2120343A1 (en) 1994-02-17
IL106520A (en) 1997-11-20
FI941424A0 (fi) 1994-03-28
NZ254787A (en) 1995-11-27
AU4704893A (en) 1994-03-03
JPH06511497A (ja) 1994-12-22
KR100311547B1 (ko) 2002-06-20
ZA935481B (en) 1994-05-16
HU9400914D0 (en) 1994-06-28
UA41291C2 (uk) 2001-09-17
NO941080L (no) 1994-05-18
TW286319B (no) 1996-09-21
ATE159951T1 (de) 1997-11-15
DE69315050T2 (de) 1998-03-05
PL178591B1 (pl) 2000-05-31
DK0607400T3 (da) 1998-01-26
HU211238A9 (en) 1995-11-28
HUT67043A (en) 1995-01-30
CN1041096C (zh) 1998-12-09
CN1085224A (zh) 1994-04-13
PH29938A (en) 1996-09-16
JP3325025B2 (ja) 2002-09-17
AU660562B2 (en) 1995-06-29
MY109633A (en) 1997-03-31
IL106520A0 (en) 1993-11-15
FI941424A (fi) 1994-05-27
FI113778B (fi) 2004-06-15

Similar Documents

Publication Publication Date Title
NO941080L (no) Fluorinerte 17 ater
AU537414B2 (en) Pyroglutamic acid derivatives
AU596389B2 (en) 1-arylpyrazoles
DE3876813D1 (de) 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
KR900701717A (ko) 2--1,3-시클로헥산디온제초제 화합물과 이를 이용한 조성물 및 식물억제방법
DE69334206D1 (de) Substituierte hexahydrobenzo(a) phenanthridine
SE8001818L (sv) Merkaptoacyldihydropyrazolkarboxylsyraderivat
DE59007487D1 (de) Hydroxyalkancarbonsäure-derivate und deren verwendung.
ES2102327A1 (es) Nuevos derivados de 2,2,6,6-tetrametilpiperidina para utilizarse como agentes estabilizantes para materiales organicos contra la luz, el calor, y la oxidacion. n
CA2084799A1 (en) Method of prevention of prostatic carcinoma with 17 beta-n-monosubstituted-carbamoyl-4-aza-5 alpha-androst-1 -en-3-ones
KR890005076A (ko) 티아디아진 유도체, 그의 제조방법 및 그 화합물을 함유하는 살충제
ATE41149T1 (de) Substituierte furazane.
SE7508328L (sv) Sett att framstella 1,2-anellerade, fem- eller sex-ledade 1,3-dikveveheterocykliska foreningar och anvendning av dess foreningar som korrosionsskyddsmedel.
ES8302734A1 (es) Procedimiento para preparar 5&#39;-n-(aminoalquil)-amino-5&#39;-deo-xiadenosina
ATE113034T1 (de) 3-(2-chloro-4-trifluoromethyl-phenoxy)-1- azetidinkarboxamide mit antikrampfmachender aktivität.
FI920403A0 (fi) Uppteckningsmaterial.
MX9706627A (es) Derivado de tiazolidinona opticamente activo.
TH13843EX (th) อนุพันธ์ฟลูออริเนทเต็ด 17 เบต้า- ซับสทิทิวเต็ด 4-เอซา-5 แอลฟ่า-แอนโดรสแทน -3-โอน
ATE37531T1 (de) Bestimmte 2-(2-substituierte benzoyl)-1,3cyclohexandione.
ITMI912104A1 (it) Poliglucosidi da idrossialchilsorbitolo